Literature DB >> 12481676

Prevalence of diabetes, impaired fasting glucose and associated risk factors in a rural area of Baluchistan province according to new ADA criteria.

A Basit1, M Z I Hydrie, K Ahmed, R Hakeem.   

Abstract

OBJECTIVE: To assess the prevalence of impaired fasting glucose (IFG) and diabetes in an adult rural population on the basis of fasting blood glucose (FBG) alone using American Diabetic Association (ADA) criteria and to assess the prevalence of and association between selected risk factors such as obesity, family history of diabetes and hypertension.
MATERIALS AND METHODS: Sixteen randomly selected villages from the Lasbella district of Baluchistan were included in this study. One month before the survey a team visited the areas; all the households located in the selected areas were approached and the family members aged 25 or above, who were available and willing to participate in the study, were recruited. On the day of survey anthroprometric and blood pressure measurements were taken; interviews were conducted to obtain demographic information and health history and fasting blood samples were collected. The blood samples were transported to the laboratory and analysed using "GOD-PAP" Enzymatic Colorimetric test method.
RESULTS: A total of 670 males and 1362 females were studied. Prevalence rate of diabetes using the ADA fasting criteria was 6.3% while the prevalence rate in males was 10.1% and in females was 4.3%. The prevalence rate of impaired fasting glucose was 4.2% in males and 2.3% in females. Overall prevalence of obesity between diabetics vs non-diabetics was 22% vs 16%, for hypertension 12.9% vs 6.5% and for positive family history of diabetes 1.6% vs 0.9% was higher among diabetics as compared to non diabetics; the difference of these parameters was statistically significant only among females (P < 0.01).
CONCLUSION: The results of this study suggest the need of continual use of OGTT for screening people at high risk of developing diabetes and perhaps also for diagnosing diabetes.

Entities:  

Mesh:

Year:  2002        PMID: 12481676

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  7 in total

Review 1.  Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysis.

Authors:  Ranil Jayawardena; Priyanga Ranasinghe; Nuala M Byrne; Mario J Soares; Prasad Katulanda; Andrew P Hills
Journal:  BMC Public Health       Date:  2012-05-25       Impact factor: 3.295

Review 2.  Prevalence of Type 2 Diabetes Mellitus in Adult Population of Pakistan: A Meta-Analysis of Prospective Cross-Sectional Surveys.

Authors:  Muhammad Adnan; Muhammad Aasim
Journal:  Ann Glob Health       Date:  2020-01-31       Impact factor: 2.462

3.  Urbanization and prevalence of type 2 diabetes in Southern Asia: A systematic analysis.

Authors:  Arsalan Cheema; Davies Adeloye; Simrita Sidhu; Devi Sridhar; Kit Yee Chan
Journal:  J Glob Health       Date:  2014-06       Impact factor: 4.413

4.  A Study of Prevalence and Association of Risk Factors for Diabetic Vasculopathy in an Urban Area of Gujarat.

Authors:  Jayesh D Solanki; Amit H Makwana; Hemant B Mehta; Pradnya A Gokhale; Chinmay J Shah
Journal:  J Family Med Prim Care       Date:  2013 Oct-Dec

Review 5.  Obesity and cardiovascular disease risk factors among the indigenous and immigrant Pakistani population: a systematic review.

Authors:  Qaisar Raza; Colleen M Doak; Aroosa Khan; Mary Nicolaou; Jaap C Seidell
Journal:  Obes Facts       Date:  2013-11-29       Impact factor: 3.942

6.  Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016-2017.

Authors:  Abdul Basit; Asher Fawwad; Huma Qureshi; A S Shera
Journal:  BMJ Open       Date:  2018-08-05       Impact factor: 2.692

7.  Diabetes in Pakistan: A systematic review and meta-analysis.

Authors:  Sohail Akhtar; Jamal Abdul Nasir; Tahir Abbas; Aqsa Sarwar
Journal:  Pak J Med Sci       Date:  2019 Jul-Aug       Impact factor: 1.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.